Multiple System Atrophy

Multiple System Atrophy is a rare, progressive brain disorder. It affects the nervous system, causing problems with movement, balance, and autonomic functions like blood pressure and bladder control. It's a type of Parkinson's disease, but it progresses much faster. Symptoms usually start in the legs and arms and can spread to the trunk and face.

Condition

What people with Multiple System Atrophy report

Every report comes from a Lived member, sent anonymously.

Have you tried Midodrine for Multiple System Atrophy?

NameHow it went

About Multiple System Atrophy

What It Is

Multiple system atrophy (MSA) is a rare, progressive brain disease that affects two systems at once: the parts of the nervous system that control movement and balance, and the autonomic nervous system, which runs automatic functions such as blood pressure, bladder control, sweating and sexual function. Nerve cells in several brain regions gradually stop working and die, which is where the name comes from. Early symptoms can look like Parkinson's disease: slowness, stiffness, tremor or clumsiness. What often sets MSA apart is how prominent the automatic-function problems are, such as lightheadedness or fainting on standing, urinary urgency or difficulty emptying the bladder, erectile dysfunction, and a quiet, shaky voice. Doctors describe two types by the main movement problem. In the parkinsonian type (MSA-P), slowness and stiffness dominate. In the cerebellar type (MSA-C), problems with balance, coordination, speech and eye movements dominate. Many people develop features of both over time. MSA was once called Shy-Drager syndrome, striatonigral degeneration or olivopontocerebellar atrophy; these older names described what are now understood as forms of the same disease.

Causes & Risk Factors

The cause of MSA is unknown. Its defining feature is a buildup of a protein called alpha-synuclein inside glial cells, the support cells that insulate nerve fibers, and this is linked to damage across several brain areas. Parkinson's disease involves the same protein, but there it collects mainly inside nerve cells, which helps explain why the two conditions overlap yet behave differently. Almost all cases are sporadic, meaning they occur without a family pattern, and no single gene has been shown to cause MSA. Some gene variants may slightly change risk, and researchers suspect a mix of genetic and environmental influences, but no environmental exposure has been clearly shown to cause it. Symptoms usually begin in a person's 50s and essentially never before age 30. Nothing a person did is known to have brought it on.

How It's Diagnosed

There is no single test that proves MSA during life; certainty comes only from examining the brain after death. Diagnosis rests on a neurologist, ideally a movement disorder specialist, recognizing a typical combination of symptoms that steadily progresses, then using tests to support it and rule out look-alikes such as Parkinson's disease, other forms of parkinsonism and inherited ataxias. Autonomic testing is central. Blood pressure is measured lying down and again after standing. A fall in the top (systolic) number of 20 or more points within three minutes of standing, without the normal rise in heart rate, points to the nervous system failing to adjust blood pressure. Bladder assessment often includes an ultrasound after urinating; leaving more than about 100 milliliters (a bit under half a cup) behind is a common finding in MSA and unusual early in Parkinson's disease. A magnetic resonance imaging (MRI) scan can show shrinkage or other changes in parts of the brainstem, cerebellum or deep brain structures that suggest MSA, and current criteria require these findings for the most confident clinical diagnosis. Other scans, such as positron emission tomography (PET) or a dopamine transporter scan, may be used in some centers. How someone responds to levodopa, the main Parkinson's medicine, also matters: a weak or fading response makes MSA more likely, although some people with MSA do benefit for a time. Because early signs overlap with other conditions, the diagnosis is often revised or firmed up over months to years.

Treatment Options

There is currently no cure and no treatment proven to slow MSA. Treatment aims to ease specific symptoms, prevent complications and keep people as independent and comfortable as possible, usually with a team that may include a neurologist, physical, occupational and speech therapists, a urologist and a sleep specialist. For slowness and stiffness, many people try levodopa, usually combined with carbidopa (as in Sinemet). It helps some people with MSA, more often those with the parkinsonian type, but the benefit is usually smaller and shorter-lived than in Parkinson's disease. Botulinum toxin injections can relax abnormal muscle postures. Low blood pressure on standing often needs several layers of treatment. Drinking more fluids, adding salt as advised, eating smaller meals, rising slowly and wearing compression stockings or an abdominal binder can reduce dizziness and falls. When these are not enough, medicines that raise blood pressure, such as midodrine or droxidopa (Northera), may be added. The trade-off is that they can push blood pressure too high when lying down, so blood pressure is checked lying flat as well as standing, and sleeping with the head of the bed raised helps. Other symptoms have their own treatments: medicines or catheterization for bladder problems, treatment for erectile dysfunction, and medicines for acting out dreams during sleep (REM sleep behavior disorder). Breathing problems during sleep can be treated with CPAP (continuous positive airway pressure, a mask that keeps the airway open) or, in some cases, a tracheostomy, a surgical opening in the windpipe. Speech therapy helps with voice and safer swallowing, and a feeding tube may be considered when swallowing becomes unsafe. Physical therapy, walkers or wheelchairs, and home safety changes support mobility and help prevent falls.

What to Expect

MSA progresses faster than Parkinson's disease. Many people need a cane or walker within a few years of the first symptoms, and later a wheelchair. Speech can become hard to understand, swallowing becomes more difficult, and bladder problems and blood pressure swings tend to grow. Anxiety and depression are also common. Median survival is about 8 to 10 years from when symptoms start, but the range is wide, and these figures describe groups of people rather than any one person's outlook. In the later stages, the main threats are pneumonia from food or liquid entering the lungs, breathing problems during sleep and, for some people, sudden death. Regular review by the care team aims to catch swallowing and breathing changes early, when steps such as CPAP or a feeding tube can make a real difference. Because needs change quickly, it helps to plan early: discussing preferences for feeding tubes, breathing support and end-of-life care, arranging home adaptations and support for caregivers, and involving palliative care, which focuses on comfort and quality of life alongside other treatment.

When to Seek Help

See a neurologist if parkinsonism or balance problems come with early fainting or lightheadedness on standing, bladder control problems or erectile dysfunction, or if Parkinson's medicines help little or stop working. Contact the care team promptly about new high-pitched noisy breathing (stridor), loud snoring or pauses in breathing during sleep, frequent coughing or choking with meals, a fever or cough that could signal pneumonia, falls or fainting, or new trouble emptying the bladder. Call 911 for severe trouble breathing, such as struggling to get air in or choking that does not clear.

Questions to Ask Your Doctor

  1. 1.What makes you think this is MSA rather than Parkinson's disease or another condition, and how certain is the diagnosis right now?
  2. 2.Is levodopa worth trying for me, and how will we judge whether it is helping?
  3. 3.How should we manage my blood pressure when I stand and when I lie down?
  4. 4.Should I have a sleep study or a swallowing evaluation, and how often should my breathing and swallowing be checked?
  5. 5.Which specialists, therapists and support services, including palliative care, should we involve now?

Last reviewed • Oct 2026

Educational content, not medical advice.